ROLE OF A NEW MACHINE MALDI TOF- MS(MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY) FOR DISEASE CAUSING MICROORGANISMS IDENTIFICATION AND TREATMENT IN ICU PATIENTS
Phase 3
- Conditions
- Health Condition 1: A419- Sepsis, unspecified organism
- Registration Number
- CTRI/2020/11/029256
- Lead Sponsor
- DR KULDEEP SINGH SINDHLIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
â??Patients/ Guardian giving written
consent will be taken
â??Age 16-60 years admitted in ICU
â?? Patients having new onset of fever
after 48 hours of admission in the
hospital.
â?? patients having new onset netropenia
Exclusion Criteria
â??Patients not giving consent.
â?? Patients already having fever at the
time of admission.
â??Patients developing fever within 48h of
admission .
- patients APACHE score of above 25
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study epidemiology and risk factor of causative organisms of septicemia in patients admitted in tertiary level ICU care. <br/ ><br>Role of MALDI TOF MASS SPECTROMETRY in Species identification of the organisms causing septicemia. <br/ ><br>Antibiotic susceptibility pattern of the organisms causing septicemia. <br/ ><br>To study incidence of candidemia and antifungal susceptibility. <br/ ><br> Clinical outcome of the patients in terms of hospital stay and number of days on ventilator. <br/ ><br>Timepoint: 1.5 years <br/ ><br>
- Secondary Outcome Measures
Name Time Method To study incidence of candidemia and antifungal susceptibility.Timepoint: 1.5 YEARS